bimekizumab,adalimumab
ucb pharmaceuticals,abbvie
['be complete', ' psa', 'be optimal', 'achieve,(-u achieve),(-u-achieve),(-uachieve)']
abst #2118 #acr22 pts with active psa who achieved increasingly stringent disease control criteria at wk 16, reported greater improvements in their physical function and pain scores, regardless of whether they were bdmard-na ve (be optimal) or tnfi-ir (be complete). 
The Division of Rheumatology is proud to serve our patients with rheumatic, auto-immune, and inflammatory disease.